Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Building Resilience During the COVID-19 Pandemic: a Randomized Controlled Trial

NCT05802875 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.

NCT NCT05802875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05802875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Building Resilience During the COVID-19 Pandemic: a Randomized Controlled Trial
Lead sponsor
Medical University Innsbruck
Phase
Not applicable
Overall status
Unknown status
Start date
April 1, 2022
Completion date
January 31, 2026
Enrollment
192 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, distress, emotional, healthy